| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.07 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.081 | 0.07 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.07 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.07 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |